Our FDA: Drug & Device Team explores the Food and Drug Administration’s updated draft guidance that eases biosimilar development by…
Read More →
Losing a loved one to the negligence of another person is devastating, but insult is added to injury when you…
Read More →
Tire blowouts can cause serious accidents. If you have been seriously injured in a car accident involving a tire blowout,…
Read More →
As part of Florida’s March 2023 tort and insurance reforms, the Florida legislature introduced a safe harbor for carriers to…
Read More →
Data centers are the physical backbone of the AI revolution. But they will place enormous demands on America’s electricity infrastructure.…
Read More →
Federal Grant Background – As part of the One Big Beautiful Bill Act, Congress established a $50 billion grant program,…
Read More →
Key Takeaways: GSA released detailed procedural guidance for protecting CUI in nonfederal systems, and a proposed FAR rule would further…
Read More →
On February 12, 2026, Anthropic CEO Dario Amodei told the New York Times that he is “open to the idea” that…
Read More →
On March 5, 2026, the Market Structure Subcommittee of the U.S. Securities and Exchange Commission’s (“SEC”) Investor Advisory Committee (“IAC”) released a…
Read More →
The booming drug rehabilitation industry promises hope to a wide range of people, but it also carries some surprising risks.…
Read More →